Last Updated : May 6, 2021
Details
Project Line:
New at CADTH
News and Events
CADTH Symposium 2021 Save the Date! CADTH is excited to announced that our 2021 CADTH Symposium will be held virtually on November 2, 3, and 4, 2021. This year’s theme is Uncertain Times, Imperfect Evidence, and the Imperative to Act.
Canadian Journal of Health Technologies
On April 22, CADTH officially launched the Canadian Journal of Health Technologies — a new, open-access journal serving the Canadian and global health technology assessment community. You can find it online at canjhealthtechnol.ca and you can subscribe to receive an electronic table of contents alert for future issues.
New CADTH Drug Reimbursement Review Video
Once Health Canada has approved a drug for use in Canada, the country’s public drug programs and cancer agencies must decide if the drug will be eligible for public reimbursement. The CADTH reimbursement review process plays an important role in their decision-making processes. We invite you to watch CADTH’s new animated video that illustrates the CADTH Drug Reimbursement Reviews.
2021 CADTH Webinar and Lecture Archives
Did you miss one of our CADTH Lectures or COVID-19 Webinars? We know how difficult it is to juggle working in health care right now and getting the latest evidence from experts, so we make sure to record everything. Here’s a list of our past events that you can now watch on our YouTube channel:
- How to Advance Gender Equity — Dr. Larissa Shamseer and Dr. Andrea Tricco (Unity Health Toronto)
- Recommendation Mapping: A New Approach to Digitizing and Presenting Living Guidelines — Dr. Holger Schünemann (McMaster University)
- Tuberculosis: International and Canadian Perspectives on the “Other” Global Pandemic — Dr. Dennis Falzon (WHO) and Caroline Newberry (Government of the Northwest Territories)
Want to learn more about our work on COVID-19? Visit our CADTH COVID Evidence Portal.
CADTH Reimbursement Reviews
CADTH recently issued the following reimbursement recommendations:
- satralizumab (Enspryng) for neuromyelitis optica spectrum disorder
- amifampridine (Ruzurgi) for Lambert-Eaton myasthenic syndrome
- infliximab (Remsima) for rheumatoid arthritis
- onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy, pediatrics
- sacubitril-valsartan (Entresto) for heart failure, NYHA Class II or III
- fremanezumab (Ajovy) for migraine
- isatuximab (Sarclisa) for multiple myeloma
- sonidegib (Odomzo) for basal cell carcinoma
- niraparib (Zejula) for ovarian cancer
- olaparib (Lynparza) for metastatic castration-resistant prostate cancer
- brigatinib (Alunbrig) for anaplastic lymphoma kinase positive non‒small cell lung cancer
- polatuzumab vedotin (Polivy) for diffuse large B-cell lymphoma
- avelumab (Bavencio) for urothelial carcinoma
- unresectable hepatocellular carcinoma — Provisional Funding Algorithm
CADTH Health Technology Reviews
CADTH recently published the following health technology reviews:
- Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury — Summary With Critical Appraisal
- Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) — Summary With Critical Appraisal
- Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review — Summary With Critical Appraisal
- Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update — Summary With Critical Appraisal
- Urethral Inserts for the Management of Adult Male Urinary Incontinence — Summary With Critical Appraisal
- Pharmacological Interventions for Vaping Cessation — Summary With Critical Appraisal
- Bupropion for Treatment Resistant Depression — Summary With Critical Appraisal
- Lenses and Spectacles to Prevent Myopia Worsening in Children — Summary With Critical Appraisal
- Interferon Gamma Release Assay for the Identification of Latent Tuberculosis Infection in Rural and Remote Settings — Summary With Critical Appraisal
- Flash Glucose Monitoring Systems in Pediatric Populations with Diabetes — Summary With Critical Appraisal
- Yttrium 90 Microspheres for Advanced, Recurrent, or Inoperable Hepatocellular Carcinoma: A Review of Clinical and Cost Effectiveness — Peer-reviewed summary With critical appraisal
- Non-Pharmacological Interventions for the Management of Concussion — Technology Review
- Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19 (Updated April 16, 2021) — Health Technology Review
- Chloroquine or Hydroxychloroquine to Prevent or Treat COVID-19 (Updated April 23, 2021) — Health Technology Review
CADTH Reference Lists
CADTH recently completed the following reference lists:
- Artificial Intelligence for the Measurement of Breast Density — Reference List
- Lidocaine Infusions for Palliative Care Patients with Cancer Pain — Reference List
- Blue Light and White Light Cystoscopy for Transurethral Resection of Bladder Tumour in People Living With Non-Muscle Invasive Bladder Cancer — Reference List
- Behavior-based Primary-Care Interventions for the Prevention of Overweight and Obesity in Children — Reference List
- Concurrent Treatment for Substance Use Disorder and Trauma-Related Comorbidities: 2021 Update — Reference List
- Post Discharge Outcomes Following Intravenous Acetaminophen Treatment in Acute Care Settings — Summary of Abstracts
- Bupropion in Patients With Sexual Dysfunction Associated With Other Antidepressant Therapy — Summary of Abstracts
- Bispectral Index Monitoring in Patients Post-Cardiac Arrest — Summary of Abstracts
- Topical Anesthetics for Minor Dermatological Procedures — Summary of Abstracts
- Substance and Nicotine Cessation Interventions for People with Problematic Substance Use — Summary of Abstracts
- Diagnosis, Management, and Re-assessment of Obstructive Sleep Apnea in Adults — Summary of Abstracts
- Flash Glucose Monitoring and Continuous Glucose Monitoring for People with Diabetes in Acute Care Settings — Summary of Abstracts
- Positive Airway Pressure and Oral Appliances for the Treatment of Obstructive Sleep Apnea in Adults — Summary of Abstracts
Other CADTH Tools
CADTH recently developed the following tools:
- Pharmaceutical Review Video: https://cadth.ca/cadth-reimbursement-reviews
- In Brief: Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer: A Clinical Review as Part of a Health Technology Assessment
- Hospital News article: Technologies with high potential to transform health care in 2021
Tell Us What You Think
We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.
CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.
Last Updated : May 6, 2021